✦ LIBER ✦

Treatment of refractory Hodgkin’s lymphoma patients with an anti-CD25 ricin A-chain immunotoxin

✍ Scribed by Schnell, R; Vitetta, E; Schindler, J; Borchmann, P; Barth, S; Ghetie, V; Hell, K; Drillich, S; Diehl, V; Engert, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

930 A clinical phase I study of an anti-

✍ R. Schnell; M.-T. Hatwig; A. Radszuhn; F. Cebe; S. Drillich; G. Schön; H. Bohlen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 171 KB

A phase I clinical trial of an anti-CD25

✍ R. Schnell; A. Radszuhn; M. -T. Hatwig; F. Cebe; S. Poyraz; S. Drillich; G. Schö 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 152 KB

A dominant linear B-cell epitope of rici

✍ D. CASTELLETTI; G. FRACASSO; S. RIGHETTI; G. TRIDENTE; R. SCHNELL; A. ENGERT; M. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Development of a new recombinant anti-CD

✍ S. Barth; B. Matthey; G. Schön; V. Diehl; A. Engert 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Intrathecal therapy of leptomeningeal CE

✍ Ulrich Herrlinger; Heinz Schmidberger; Rainer Buchholz; Manfred Wehrmann; Daniel 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 526 KB

Treatment of refractory Hodgkin’s diseas

✍ Cristoph Renner; Frank Hartmann; M. Pfreundschuh 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 164 KB